PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,568,000 | +7.3% | 1,767,680 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $5,188,000 | +7.3% | 1,782,834 | +4.0% | 0.00% | 0.0% |
| Q1 2020 | $4,835,000 | -54.9% | 1,714,587 | -48.1% | 0.00% | 0.0% |
| Q4 2019 | $10,710,000 | +188.0% | 3,300,510 | +91.6% | 0.00% | 0.0% |
| Q3 2019 | $3,719,000 | -39.1% | 1,722,199 | -11.5% | 0.00% | 0.0% |
| Q2 2019 | $6,111,000 | -18.9% | 1,946,492 | -3.9% | 0.00% | -50.0% |
| Q1 2019 | $7,531,000 | -32.0% | 2,024,735 | -47.0% | 0.00% | 0.0% |
| Q4 2018 | $11,080,000 | +125.9% | 3,821,136 | +104.9% | 0.00% | +100.0% |
| Q3 2018 | $4,904,000 | +6.3% | 1,864,995 | -5.4% | 0.00% | 0.0% |
| Q2 2018 | $4,613,000 | -20.9% | 1,971,736 | -0.6% | 0.00% | -50.0% |
| Q1 2018 | $5,829,000 | +0.4% | 1,982,833 | -6.5% | 0.00% | 0.0% |
| Q4 2017 | $5,807,000 | -14.3% | 2,119,754 | +6.0% | 0.00% | -33.3% |
| Q3 2017 | $6,778,000 | +55.0% | 1,999,685 | +12.9% | 0.00% | +50.0% |
| Q2 2017 | $4,373,000 | -9.9% | 1,770,643 | -17.2% | 0.00% | 0.0% |
| Q1 2017 | $4,856,000 | -4.2% | 2,139,365 | -10.5% | 0.00% | 0.0% |
| Q4 2016 | $5,068,000 | -19.2% | 2,391,206 | +27.8% | 0.00% | -33.3% |
| Q3 2016 | $6,269,000 | +24.9% | 1,871,496 | +17.0% | 0.00% | 0.0% |
| Q2 2016 | $5,021,000 | -0.9% | 1,599,491 | +5.1% | 0.00% | 0.0% |
| Q1 2016 | $5,069,000 | -7.9% | 1,522,257 | -2.1% | 0.00% | 0.0% |
| Q4 2015 | $5,504,000 | -19.9% | 1,555,072 | +13.8% | 0.00% | -25.0% |
| Q3 2015 | $6,874,000 | -3.4% | 1,366,750 | +23.5% | 0.00% | 0.0% |
| Q2 2015 | $7,118,000 | -4.9% | 1,107,121 | +4.1% | 0.00% | 0.0% |
| Q1 2015 | $7,482,000 | -3.7% | 1,063,684 | +5.6% | 0.00% | -20.0% |
| Q4 2014 | $7,768,000 | -0.8% | 1,007,548 | -3.9% | 0.01% | 0.0% |
| Q3 2014 | $7,829,000 | -16.6% | 1,048,244 | +8.1% | 0.01% | -16.7% |
| Q2 2014 | $9,389,000 | +38.1% | 970,028 | +18.6% | 0.01% | +20.0% |
| Q1 2014 | $6,797,000 | +4.7% | 817,960 | +6.3% | 0.01% | 0.0% |
| Q4 2013 | $6,491,000 | +24.4% | 769,167 | +17.5% | 0.01% | +25.0% |
| Q3 2013 | $5,218,000 | +0.5% | 654,699 | -2.7% | 0.00% | -20.0% |
| Q2 2013 | $5,192,000 | – | 672,547 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |